Advertisement
Advertisement
U.S. Markets open in 5 hrs 54 mins
Advertisement
Advertisement
Advertisement
Advertisement

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
37.18+0.03 (+0.08%)
At close: 04:00PM EDT
38.75 +1.57 (+4.22%)
After hours: 07:44PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/24/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.89
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 378.58
52 Week Low 332.44
50-Day Moving Average 339.69
200-Day Moving Average 349.87

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 31.37M
Shares Outstanding 586.22M
Implied Shares Outstanding 6N/A
Float 874.41M
% Held by Insiders 16.27%
% Held by Institutions 180.12%
Shares Short (Jan 30, 2023) 47.35M
Short Ratio (Jan 30, 2023) 46.22
Short % of Float (Jan 30, 2023) 49.75%
Short % of Shares Outstanding (Jan 30, 2023) 48.63%
Shares Short (prior month Dec 29, 2022) 46.63M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-814.16%

Management Effectiveness

Return on Assets (ttm)-21.62%
Return on Equity (ttm)-45.76%

Income Statement

Revenue (ttm)51.4M
Revenue Per Share (ttm)0.68
Quarterly Revenue Growth (yoy)84.10%
Gross Profit (ttm)-186.75M
EBITDA -411.07M
Net Income Avi to Common (ttm)-442.02M
Diluted EPS (ttm)-2.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)828.19M
Total Cash Per Share (mrq)10.53
Total Debt (mrq)97.65M
Total Debt/Equity (mrq)11.84
Current Ratio (mrq)6.55
Book Value Per Share (mrq)7.96

Cash Flow Statement

Operating Cash Flow (ttm)-298.07M
Levered Free Cash Flow (ttm)-215.67M
Advertisement
Advertisement